Global Value & Access Director, Autoimmune Cell Therapies

Kite Pharma, Inc.

El Segundo (CA)

Híbrido

USD 206 000 - 293 000

Tempo integral

Há 9 dias

Recebe uma resposta deste empregador

O teu currículo e carta de apresentação, adaptados exatamente ao que estão a contratar.

Ultrapassa os filtros ATS

Vantagens oferecidas por esta oferta de emprego

Medical insurance
Dental insurance
Vision insurance
Life insurance
Bonus eligibility

Resumo da oferta

Kite Pharma, Inc. is seeking a Director, Global Value & Access Strategy (GVAS), Cell-therapy Autoimmune. This role is hybrid (3 days onsite) in El Segundo, Thousand Oaks, or Foster City, CA, reporting to the Senior Director, GVA Lead.

You will drive global market access and evidence generation for autoimmune cell therapies. You will partner with Clinical, HEOR, Medical Affairs, Regulatory, and Commercial teams to shape payer strategies, inform development plans, and support future launches

Qualificações

  • 8+ years with a PhD/PharmD or 10+ years with MS/MA, MBA, PharmD, PhD or equivalent
  • 12+ years with BS/BA
  • 3+ years of direct experience supporting autoimmune programs
  • Strong understanding of autoimmune disease treatment paradigms
  • Experience with cell therapy and/or gene therapy strongly preferred

Responsabilidades

  • Serve as the Global Market Access representative for assigned autoimmune programs.
  • Lead the development of global value and access strategies across the product lifecycle, from early development through launch and lifecycle management.
  • Ensure payer, HTA, and health system perspectives are reflected in development, evidence generation, pricing, and commercialization strategies.
  • Partner with regional and country access teams to develop integrated global-to-local reimbursement strategies.
  • Collaborate with HEOR, Medical Affairs, Clinical Development, and Commercial functions to develop value evidence strategies.

Conhecimentos

Strong strategic thinking
Analytical skills
Problem-solving skills
Excellent communication skills
Cross-functional collaboration

Formação académica

PhD/PharmD
MS/MA, MBA, PharmD, PhD
BS/BA

Descrição da oferta de emprego

Kite Pharma, Inc. is seeking a Director, Global Value & Access Strategy (GVAS), Cell-therapy Autoimmune. This role is hybrid (3 days onsite) in El Segundo, Thousand Oaks, or Foster City, CA, reporting to the Senior Director, GVA Lead.

You will drive global market access and evidence generation for autoimmune cell therapies. You will partner with Clinical, HEOR, Medical Affairs, Regulatory, and Commercial teams to shape payer strategies, inform development plans, and support future launches

Obtém a tua avaliação gratuita e confidencial do currículo.

ou arrasta e larga o ficheiro aqui.

Similar jobs

Ofertas semelhantes que vale a pena comparar

Global Value & Access Director - Autoimmune Cell Therapy
Global Value & Access Director - Autoimmune Cell Therapy

Kite Pharma, Inc. • Thousand Oaks (CA)

Híbrido
USD 180 000 - 240 000
Global Value & Access Director, Autoimmune Cell Therapy
Global Value & Access Director, Autoimmune Cell Therapy

1110 Kite Pharma, Inc. • El Segundo (CA)

Híbrido
USD 226 000 - 293 000
Benefits package
Discretionary bonus
Stock-based long-term incentives
+1
Global Access Director, Autoimmune Cell Therapies
Global Access Director, Autoimmune Cell Therapies

Kite Pharma, Inc. • San Francisco (CA)

Híbrido
USD 226 000 - 293 000
Director, Global Value & Access (Cell Therapy) – Hybrid
Director, Global Value & Access (Cell Therapy) – Hybrid

Gilead Sciences Inc. • El Segundo (CA)

Híbrido
USD 206 000 - 266 000
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

Kite Pharma, Inc. • Thousand Oaks (CA)

Híbrido
USD 180 000 - 240 000
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

Kite Pharma, Inc. • El Segundo (CA)

Híbrido
USD 206 000 - 293 000
Medical insurance
Dental insurance
Vision insurance
+2
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

1110 Kite Pharma, Inc. • El Segundo (CA)

Híbrido
USD 226 000 - 293 000
Benefits package
Discretionary bonus
Stock-based long-term incentives
+1
Global Autoimmune CAR-T Medical Affairs Director
Global Autoimmune CAR-T Medical Affairs Director

Bristol-Myers Squibb Co • New Jersey

Híbrido
USD 207 000 - 251 000
Flexible Time Off
11 paid company holidays
Volunteer days
+1
Director, US Payer & Value Marketing — CAR-T Access Strategy
Director, US Payer & Value Marketing — CAR-T Access Strategy

Kite Pharma • Santa Monica (CA)

Híbrido
USD 206 000 - 266 000
Discretionary annual bonus
Discretionary stock-based incentives
Paid time off
+1
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

Kite Pharma, Inc. • San Francisco (CA)

Híbrido
USD 226 000 - 293 000